Viewing Study NCT07146932


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-02-20 @ 4:43 PM
Study NCT ID: NCT07146932
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-22
First Post: 2025-08-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Bambini Teens Exoskeleton for Pediatric Cerebral Palsy
Sponsor: COSMO ROBOTICS CO., Ltd
Organization:

Study Overview

Official Title: Evaluating the Bambini Teens Exoskeleton for Pediatric Cerebral Palsy
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to evaluate the safety and effectiveness of the Bambini Teens exoskeleton as a gait training tool in children aged 5 to 14 years diagnosed with cerebral palsy (CP). The main questions it aims to answer are:

* Is the Bambini Teens exoskeleton device safe and feasible as a gait training intervention for children with cerebral palsy, without resulting in a significant incidence of device-related serious adverse events?
* Is it feasible for physical therapists to use the Bambini Teens exoskeleton as a gait training intervention for children with cerebral palsy, meaning participants will successfully complete the training sessions?
* Will participants' mobility, specifically their self-selected walking speed, improve after receiving gait training using the Bambini Teens exoskeleton compared to baseline measurements?

Researchers will compare participants' mobility measured at baseline to their mobility after the intervention to see if improvements occur.

Participants will:

* Complete 6 gait training sessions using the Bambini Pediatric Exoskeleton, monitored by a licensed physical therapist.
* Each training session will be 30 minutes long, conducted 2-3 times per week for approximately 3 weeks.
* Undergo evaluations at baseline and post-intervention (after approximately 3 weeks), with each evaluation session lasting approximately 2 hours.
* May also participate in optional motor evaluations.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: